Compound ID | 1713
Class: SrtA inhibitor
Spectrum of activity: | Gram-positive |
Details of activity: | Interferes with the adhesion of Staphylococcal aureus |
Institute where first reported: | Kyoto Pharmaceutical University, Japan |
Year first mentioned: | 1996 |
Highest developmental phase: | Preclinical |
Chemical structure(s): | |||||||||||
|
|